
To examine the rationale for long-term use of medications in the management of zzso to provide an overview of published scientific information on their safety and zzso and to provide guidance to patients and practitioners regarding risks and benefits of zzso 

Original reports and reviews obtained through electronic database searches on zzso drugs supplemented by a manual search of zzso 

English-language articles that discussed the role of medications in the treatment of human zzso and studies that evaluated their safety and efficacy for a minimum of 24 zzso 

Studies were reviewed by experts in the fields of nutrition, zzso and eating disorders to evaluate study design and the zzso of zzso zzso 

The long-term use of medications in the management of obesity is consistent with the current consensus that obesity responds poorly to short-term zzso Net weight loss attributable to medication is modest, ranging from 2 to 10 zzso but patients taking active drug are more likely to lose zzso or more of initial body zzso Weight loss tends to reach a plateau by 6 zzso Weight remains below baseline throughout treatment, although some studies show partial weight regain despite continued drug zzso Most adverse effects are mild and zzso but rare serious outcomes have been zzso 

zzso for zzso when combined with appropriate behavioral approaches to change diet and physical activity, helps some obese patients lose weight and maintain weight loss for at least 1 zzso There is little justification for the short-term use of zzso medications, but few studies have evaluated their safety and efficacy for more than 1 zzso Until more data are available, zzso cannot be recommended for routine use in obese individuals, although it may be helpful in carefully selected zzso 

